Preparation of superoxide dismutase loaded chitosan microspheres:: Characterization and release studies

被引:24
作者
Celik, Ozge
Akbuga, Julide [1 ]
机构
[1] Univ Marmara, Dept Pharmaceut Biotechnol, TR-34668 Istanbul, Turkey
[2] Halic Univ, Dept Mol Biol & Genet, Istanbul, Turkey
关键词
chitosan; superoxide dismutase; microspheres; PEG; controlled release; protein;
D O I
10.1016/j.ejpb.2006.08.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Superoxide dismutase (SOD) is the most potent antioxidant enzyme. In this study, SOD was encapsulated in chitosan microspheres to obtain suitable sustained protein delivery. Protein-loaded chitosan microspheres with various formulations were prepared based on complex coacervation process. Due to the inherent characteristic of SOD, high encapsulation efficiency could not be obtained with simple preparation method. The pH of chitosan solution is 3.0; when the chitosan microspheres were prepared with this solution, encapsulation was low. Therefore, several strategies have been tested to increase the encapsulation efficiency and good results have been obtained. 70-80% protein encapsulation efficiency was obtained. The addition of PEG to the protein solution enhanced the encapsulation efficiency also. Mean sizes of microspheres were between 1.38 and 1.94 mu m. Factors affecting the release behaviour of SOD from microspheres have been studied. They included pH values of chitosan solution (the pH of chitosan solution is 3.0), addition of PEG to the protein solution and the use of adsorption technique, In general, biphasic release profiles were obtained with these formulations. The protein activity changed between 70 and 100% during the release. In general, the protein activity remained in acceptable limits. The SOD encapsulated chitosan microspheres can be prepared by changing the pH or addition of PEG, allowing the safe incorporation of protein for controlled release. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:42 / 47
页数:6
相关论文
共 25 条
[1]  
Aoki H, 1997, CHEM PHARM BULL, V45, P1327
[2]   SUPPRESSION OF ISCHEMIA-REPERFUSION INJURY BY LIPOSOMAL SUPEROXIDE-DISMUTASE IN RATS SUBJECTED TO TOURNIQUET SHOCK [J].
AOKI, Y ;
NATA, M ;
ODAIRA, T ;
SAGISAKA, K .
INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 1992, 105 (01) :5-9
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Intravenous administration of superoxide dismutase entrapped in long circulating liposomes [J].
Corvo, ML ;
Boerman, OC ;
Oyen, WJG ;
Van Bloois, L ;
Cruz, MEM ;
Crommelin, DJA ;
Storm, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1419 (02) :325-334
[5]   Liposomal formulations of Cu,Zn-superoxide dismutase: Physicochemical characterization and activity assessment in an inflammation model [J].
Corvo, ML ;
Martins, MB ;
Francisco, AP ;
Morais, JG ;
Eugenia, M ;
Cruz, M .
JOURNAL OF CONTROLLED RELEASE, 1997, 43 (01) :1-8
[6]   Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes [J].
Dokka, S ;
Toledo, D ;
Shi, XG ;
Castranova, V ;
Rojanasakul, Y .
PHARMACEUTICAL RESEARCH, 2000, 17 (05) :521-525
[7]   Enhancement of nasal absorption of insulin using chitosan nanoparticles [J].
Fernández-Urrusuno, R ;
Calvo, P ;
Remuñán-López, C ;
Vila-Jato, JL ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1576-1581
[8]  
Giovagnoli S, 2004, AAPS PHARMSCITECH, V5
[9]   ENTRAPMENT OF PROTEINS IN POLY(L-LACTIDE) MICROSPHERES USING REVERSED MICELLE SOLVENT EVAPORATION [J].
HAYASHI, Y ;
YOSHIOKA, S ;
ASO, Y ;
PO, ALW ;
TERAO, T .
PHARMACEUTICAL RESEARCH, 1994, 11 (02) :337-340
[10]  
Illum L, 1998, PHARM RES-DORDR, V15, P1326